Literature DB >> 26825120

Evaluation of two new commercial immunochromatographic assays for the rapid detection of OXA-48 and KPC carbapenemases from cultured bacteria.

Youri Glupczynski1, Stéphanie Evrard2, Isabelle Ote3, Pascal Mertens3, Te-Din Huang2, Thierry Leclipteux3, Pierre Bogaerts2.   

Abstract

BACKGROUND: Rapid detection and confirmation of carbapenemases remains very challenging for diagnostic laboratories.
OBJECTIVES: The objective of this study was to assess the performance of two new immunochromatographic (IC) commercial assays for the rapid detection of OXA-48-producing and KPC-producing Enterobacteriaceae in pure bacterial isolates.
METHODS: A panel of 92 bacterial isolates predominantly including carbapenem-non-susceptible Enterobacteriaceae with previously defined carbapenem resistance mechanisms was tested. Then, 342 consecutive carbapenem-non-susceptible Enterobacteriaceae isolates referred to the reference laboratory were investigated prospectively in parallel with other phenotypic tests and with multiplex PCR and sequencing as the gold standard.
RESULTS: In the collection panel, each of the two IC assays correctly detected all 30 OXA-48-like-producing isolates and 25 KPC-producing isolates, whatever the species, their association with other β-lactamases and the level of resistance to carbapenems. All other carbapenemase producers and all non-carbapenemase-producing isolates yielded negative results with both tests. In the prospective evaluation, all OXA-48-like-producing Enterobacteriaceae isolates (n = 130) and KPC-producing Enterobacteriaceae isolates (n = 33) were correctly detected by the individual IC assays, while 179 non-OXA-48-like-producing and non-KPC-producing strains (137 non-carbapenemase producers and 42 isolates belonging to other carbapenemase family types) yielded negative results. Thus, each assay yielded 100% sensitivity and 100% specificity for the detection of OXA-48-like or KPC enzymes, respectively, at 15 min.
CONCLUSIONS: The two IC assays allow rapid and reliable direct confirmation of OXA-48 and KPC carbapenemases from culture colonies and appear to be very useful additions to the existing tests, obviating the need for more costly characterization by molecular amplification methods.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26825120     DOI: 10.1093/jac/dkv472

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  26 in total

1.  Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.

Authors:  François Caméléna; Aurélie Cointe; Vincent Mathy; Claire Hobson; Catherine Doit; Béatrice Bercot; Dominique Decré; Isabelle Podglajen; Laurent Dortet; Audrey Monjault; Philippe Bidet; Stéphane Bonacorsi; André Birgy
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

2.  Comparison of 11 Phenotypic Assays for Accurate Detection of Carbapenemase-Producing Enterobacteriaceae.

Authors:  Pranita D Tamma; Belita N A Opene; Andrew Gluck; Krizia K Chambers; Karen C Carroll; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

3.  Noncarbapenemase OXA-48 Variants (OXA-163 and OXA-405) Falsely Detected as Carbapenemases by the β Carba Test.

Authors:  Laurent Dortet; Thierry Naas
Journal:  J Clin Microbiol       Date:  2017-02       Impact factor: 5.948

4.  Rapid Detection of Carbapenemases in Enterobacteriaceae: Evaluation of the Resist-3 O.K.N. (OXA-48, KPC, NDM) Lateral Flow Multiplexed Assay.

Authors:  David W Wareham; Muhd Haziq F Abdul Momin
Journal:  J Clin Microbiol       Date:  2017-02-01       Impact factor: 5.948

5.  Detection of Carbapenemase-Producing Enterobacteriaceae in Positive Blood Culture Using an Immunochromatographic RESIST-4 O.K.N.V. Assay.

Authors:  Aurélie Cointe; Stéphane Bonacorsi; Jeanne Truong; Claire Hobson; Catherine Doit; Audrey Monjault; Philippe Bidet; André Birgy
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 6.  Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates.

Authors:  Pranita D Tamma; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

7.  Rapid Identification of OXA-48 and OXA-163 Subfamilies in Carbapenem-Resistant Gram-Negative Bacilli with a Novel Immunochromatographic Lateral Flow Assay.

Authors:  Fernando Pasteran; Laurence Denorme; Isabelle Ote; Sonia Gomez; Denise De Belder; Youri Glupczynski; Pierre Bogaerts; Barbara Ghiglione; Pablo Power; Pascal Mertens; Alejandra Corso
Journal:  J Clin Microbiol       Date:  2016-08-17       Impact factor: 5.948

8.  Rapid Detection and Characterization of Carbapenemases in Enterobacterales with a New Modified Carbapenem Inactivation Method, mCIMplus.

Authors:  Morgane Petit; François Caméléna; Aurélie Cointe; Thibaut Poncin; Manel Merimèche; Stéphane Bonacorsi; André Birgy; Béatrice Berçot
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

9.  CTX-M-15-Producing Shewanella Species Clinical Isolate Expressing OXA-535, a Chromosome-Encoded OXA-48 Variant, Putative Progenitor of the Plasmid-Encoded OXA-436.

Authors:  Agnès B Jousset; Laura Dabos; Rémy A Bonnin; Delphine Girlich; Anaïs Potron; Nicolas Cabanel; Laurent Dortet; Philippe Glaser; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

10.  Comparison of Phenotypic Tests and an Immunochromatographic Assay and Development of a New Algorithm for Detection of OXA-48-like Carbapenemases.

Authors:  Florian Koroska; Stephan Göttig; Martin Kaase; Jörg Steinmann; Sören Gatermann; Julian Sommer; Thorsten Wille; Georg Plum; Axel Hamprecht
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.